Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
Diabetes Care|May 22, 2016
HLA-A*24 Carrier Status and Autoantibody Surges Posttransplantation Associate With Poor Functional Outcome in Recipients of an Islet AllograftSimke Demeester, Else M Balke, Bart J Van der Auwera, et al.
Diabetes|April 2, 2010
Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimersJurjen H Velthuis, Wendy W Unger, Joana R F Abreu, et al.
The Lancet. Diabetes & Endocrinology|January 26, 2023
Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trialMargaretha M Visser, Sara Charleer, Steffen Fieuws, et al.
Journal of Diabetes Science and Technology|September 29, 2022
The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 TrialMargaretha Martha Visser, Sara Charleer, Steffen Fieuws, et al.
Diabetologia|November 4, 2020
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetesBart Keymeulen, André van Maurik, Dave Inman, et al.
Plos One|June 2, 2017
Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide RatioAnnelien Van Dalem, Simke Demeester, Eric V Balti, et al.
Diabetes Care|January 14, 2015
Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetesSimke Demeester, Bart Keymeulen, Leonard Kaufman, et al.
British Journal of Clinical Pharmacology|December 20, 2018
Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti-CD3ε mAb in new-onset type 1 diabetes mellitus patientsGeorgios Vlasakakis, Antonella Napolitano, Ruth Barnard, et al.
Cell Transplantation|May 2, 2023
Comparison of Omentum and Subcutis as Implant Sites for Device-Encapsulated Human iPSC-Derived Pancreatic Endoderm in Nude RatsJolien R Nijns, Ines De Mesmaeker, Krista G Suenens, et al.
Plos One|October 1, 2014
Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in miceLei Ding, Conny A Gysemans, Geert Stangé, et al.
Pageof 14